Skip to main content

Hims & Hers signals beyond the news: 36+ signals from 5 sources

The latest Hims & Hers signal on this page is from Nov 17, 2026 (Patents): "Hims, Inc.'s patent output is steady: 1 grant in the past year, 1 in the past 30 days." The busiest sources: LinkedIn (15+), YouTube (12) and Reddit (4).

Privatehims.com

Get Hims & Hers' live signals in Claude or ChatGPT, or by API

AskWhat changed at Hims & Hers this week? Use Autobound signals for hims.com.
Signals
36+
Sources
5
Last 90 days
16
Latest
Nov 17, 2026

Source: Autobound Signal API · 57 signals tracked for Hims & Hers · updated

Other signals · latest 10

Latest Hims & Hers signals by source

36+ signals for Hims & Hers across 5 sources.

  1. Patents · Patent pace

    Hims, Inc.'s patent output is steady: 1 grant in the past year, 1 in the past 30 days.

    Over the past year Hims, Inc. received 1 US patent grant; the recent pace (1 in 90 days) is steady versus its trailing baseline.

    Grants, 12 months
    1
    Grants, 90 days
    1
    Grants, 30 days
    1
    USPTO assignee
    Hims, Inc.

    Google Patents

  2. Patents · Patent grant

    Hims was granted a patent for a gummy product design.

    In November 2026 Hims received design protection for the appearance of a gummy used in consumer wellness products.

    Grant date
    Nov 10, 2026
    Inventors
    Jakob Tiefenbacher, Maxime Dubreucq

    Google Patents

  3. LinkedIn

    Hims works with Eli Lilly to expand Zepbound and Foundayo access through unified care.

    We’re working with Eli Lilly and Company to expand access to Zepbound and Foundayo. No more switching to third-party platforms, no more split payments. Just one, unified care experience that is simple, straightforward, and personal. Read more, including important info: https://lnkd.in/g3zJcQ3p

    Likes
    362
    Comments
    3
    Tags
    Partnership, Pharmaceuticals
    Initiatives
    unified care platform expansion with Lilly

    LinkedIn

  4. LinkedIn

    Hims CEO says the FDA allows compounding of six peptides, Hims plans Peptides+ service.

    Yesterday the Department of Health and Human Services moved to allow compounding of six peptides while formal rulemaking is underway, giving people a real alternative to the dangerous gray market so many are already using, often without a clinician involved or knowing what’s actually in the product. This draft...

    Likes
    320
    Comments
    9
    Tags
    Regulations, Pharmaceuticals, Healthcare Operations
    Initiatives
    launching Peptides+ specialty service

    LinkedIn

  5. Podcasts · Tech adoption

    Hims House discusses Hims & Hers: tech adoption

    "Himes has kind of set their lineup in terms of who's going to be defending them. And they have a national firm, Baker Hostetler, which is a well-known national firm."

    Podcast
    Hims House
    Episode
    🚨 THE FTC SUES HIMS & HERS -- Full breakdown with Gaston Kroub
    Speaker
    Gaston Kroub
    Speaker role
    Third party

    Hims House

  6. Reddit · Customer feedback

    A Hims subscriber is considering leaving the service due to high medication and membership fees and difficulty accessing prescription records in the app.

    Post: "Switching from Hims to Rift"

    Subreddit
    r/joinrift
    Upvotes
    11
    Comments
    24
    Sentiment
    Negative

    r/joinrift

  7. Reddit · Customer feedback

    A customer canceled their $149/month Hims subscription after criticizing unexpected recurring fees and unhelpful support regarding an early refill request for Wegovy.

    Post: "So glad I canceled my $149.00 /month worthless subscription."

    Subreddit
    r/HIMS
    Upvotes
    0
    Comments
    2
    Sentiment
    Negative

    r/HIMS

  8. YouTube

    Q2 Regnskaber fra Hims & Hers, Sea LTD og kæmpe NVIDIA nyheder - Mads giver sit take

    NewDeal Invest reviews Q2 earnings for Hims & Hers, Sea LTD, and NVIDIA's financial deal.

    Channel
    NewDeal Invest
    Views
    6
    Comments
    0
    Tags
    Financial Analysis, Company Earnings, Technology News

    YouTube (NewDeal Invest)

  9. Podcasts · Industry prediction

    Hims House discusses Hims & Hers: industry prediction

    "the industry check suggests for HIMSS and Rho peptides are more of a 2027 story in terms of revenue. Is that right? That's right."

    Podcast
    Hims House
    Episode
    Ryan MacDonald: Peptides could be a $30B+ market, and Hims is positioned to win meaningful share
    Speaker
    Ryan McDonald
    Speaker role
    Third party

    Hims House

  10. YouTube

    😱 $HIMS EARNINGS PART 1 - KEY FINANCIAL HIGHLIGHTS #hims #investing #wealth #stockmarket #stocks

    Hims Q1 earnings show subscriber growth and raised guidance, but significant margin compression and net losses.

    Channel
    Earn It - Save It - Invest It
    Views
    101
    Comments
    0
    Tags
    Earnings Report, Strategic Shift, GLP-1 Medications, Telehealth

    YouTube (Earn It - Save It - Invest It)

Showing 10 of 36+ signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Hims & Hers with the Signal API

One POST /v1/companies/enrich call with hims.com returns Hims & Hers signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "hims.com",
    "signal_types": ["reddit-company","podcast-company","glassdoor-company",
      "product-reviews","linkedin-post-company","twitter-company-posts",
      "youtube-company","website-intelligence","patents-company",
      "federal-contract-award","conference-speaker","hackernews",
      "producthunt-launch","seo-traffic"],
    "limit": 20
  }'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Company pages

Questions about Hims & Hers other signals

What signals does Autobound track for Hims & Hers besides news and filings?
This page lists 36+ signals for Hims & Hers from 5 sources: LinkedIn (15+), YouTube (12), Reddit (4), Patents (3) and Podcasts (2). Every row is dated, and most link to the post, review or record.
What are people saying about Hims & Hers online?
The newest posts on this page: Sep 2, 2026, Podcasts (Hims House): Hims House discusses Hims & Hers: tech adoption. Aug 30, 2026, Reddit (r/joinrift): A Hims subscriber is considering leaving the service due to high medication and membership fees and difficulty accessing prescription records in the app. Aug 29, 2026, Reddit (r/HIMS): A customer canceled their $149/month Hims subscription after criticizing unexpected recurring fees and unhelpful support regarding an early refill request for Wegovy.
Has Hims & Hers been granted patents recently?
Yes. The newest grant on this page: Nov 10, 2026, Patents (Google Patents): Hims was granted a patent for a gummy product design.

Page updated , the date of the newest row on this page.

Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.

Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.

Data as of .

How this data is built →Get it from the Signal API →